Scintigraphic evaluation of neuroendocrine tumors

Applied Radiology

Volumn 30, Issue 6, 2001, Pages 11-17

  Hanson, M W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; INDIUM 111; IODINE 123; IODINE 131; NEUROTRANSMITTER; NORADRENALIN; OCTREOTIDE; PENTETREOTIDE; PENTETREOTIDE IN 111; POTASSIUM IODIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

AGED; APUD CELL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; FEMALE; HUMAN; INJECTION; INSULINOMA; ISOTOPE LABELING; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; SCINTIGRAPHY;

EID: 0034954941     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0160-9963(01)80204-1     Document Type: Article

References (33)

1. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
2. Adrenal medulla imaging with I-131-p-iodobenzylguanidine
3. Radiolabeled adrenergic neuron blocking agents: Adrenomedullary imaging with I-131 iodobenzylguanidine
4. Imaging the primate adrenal medulla with I-123 and I-131 meta-iodobenzylguanidine. Concise communication
5. Scintigraphic localization of pheochromocytoma
6. Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors
7. Uptake of Iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: A histophatological comparison
8. The role of I-131-MIBG in the diagnosis and therapy of carcinoids
9. Carcinoid tumors: Iodine-131 MIBG scintigraphy
10. Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma
11. Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit
12. Radiolabeled metaiodobenzylguanidine: Pharmacology and clinical studies
13. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131] Iodobenzylguanidine (I-131 MIBG) in man: Evaluation by scintigraphy
14. I-131 meta-iodobenzylguanidine scintigraphy of neuroblastomas
15. Metaiodobenzylguanidine (MIBG) imaging in neuroblastoma
16. Sensitivity and utility of the I-131 MIBG scan in childhood neuroblastoma
17. Somastostatin (first of two parts)
18. Somastostatin (second of two parts)
19. Somatostatin-receptor imaging in the localization of endocrine tumors
20. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin
21. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors
22. Somatostatin receptor scintigraphy with [111 In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
23. Somatostatin receptor imaging: Tumor localization, detection, and therapeutic implications
24. Somatostatin receptor scintigraphy
25. Peptide receptor imaging and therapy
26. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma
27. I-131 MIBG scintigraphy of neuroectodermal tumors: Comparison between I-131 MIBG and In-111 DTPA-Octreotide
28. A comparison of I-123 MIBG and In-111 octreotide in patients with carcinoid and pancreatic neuroendocrine neoplasms
29. In-111-octreotide vs. I-123-MIBG scintigraphy in the detection of carcinoids and its metastases
30. Role of 131I-metaiodobenzylguanidine therapy in carcinoids
31. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues
32. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors
33. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy